Trial intelligence / Profile preview

Topical Dexamethasone vs Lidocaine for Post-intubation Sore Throat

NCT06266481Phase 3Recruiting

Sponsor
Pharos University in Alexandria
Start
Mar 2024
Primary completion
Apr 2024
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

Phase 3, randomised trial of dexamethasone iontophoretic patch in postoperative sore throat (POST) (2 arms), sponsored by Pharos University in Alexandria. Primary endpoint: Post-operative Sore Throat Severity at 6 hours. Started Mar 2024; status: recruiting.

02

Drugs

dexamethasone iontophoretic patch
03

Conditions

postoperative sore throat (POST)

Beyond the preview

Go deeper on NCT06266481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06266481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call